Endpoint Strategy in Pragmatic Trials: NIH Collaboratory Virtual Workshop (September 2026)

September 8-9, 2026: This 2-day workshop explored the factors involved in selecting endpoints and interpreting treatment effects in embedded pragmatic clinical trials (ePCTs) to best inform decision-making. A series of panels addressed considerations for selecting endpoints that reliably measure concepts of interest in ePCTs; influential factors in the analysis and interpretation of treatment effects; applications of multicomponent and hierarchical endpoints; and real-world examples of various endpoint strategies in ePCTs.

Agenda, Slides, and Recordings

Day 1: September 8

Welcome and Introduction

Wendy Weber, ND, PhD, MPH
David Shurtleff, PhD
Kevin Weinfurt, PhD

Opening Presentation: Defining the Endpoint: Where Evidence Begins

Kevin Weinfurt, PhD

▶️ Watch the recording

Session 1: Aiming for Impact: What is the Right Concept to Target?

Moderator: Steven George, PT, PhD, FAPTA

Panel:

  • Michael Ho, MD, PhD
  • Frederick Masoudi, MD, MSPH, MACC, FAHA
  • Miguel Vazquez, MD
  • Tracy Wang, MD, MHS, MSc
  • Wendy Weber, ND, PhD, MPH

▶️ Watch the recording

Session 2: The Estimands Framework: Aligning Objectives, Endpoints, and Analyses

Moderator: Liz Turner, PhD

Panel:

  • Elizabeth Colantuoni, PhD, ScM
  • Fan Li, PhD
  • Richard Skolasky, Jr, MA, ScD
  • Hulin Wu, PhD

▶️ Watch the recording

Session 3: Working With Multiple Outcomes: Multicomponent Endpoints and Beyond

Moderator: Emily O’Brien, PhD

Panel:

  • Julie Fritz, PhD, PT
  • Patrick Heagerty, PhD
  • Eric Roseen, DC, PhD
  • Pamela Shaw, PhD, MS
  • Qilu Yu, PhD

▶️ Watch the recording

Summary and Concluding Remarks

Steven George, PT, PhD, FAPTA
Emily O’Brien, PhD
Liz Turner, PhD
Kevin Weinfurt, PhD

Day 2: September 9

Welcome and Introduction

Wendy Weber, ND, PhD, MPH
David Shurtleff, PhD
Kevin Weinfurt, PhD

Opening Presentation: Moving From Measurement to Meaning

Kevin Weinfurt, PhD

▶️ Watch the Recording

Session 4: Unpacking Uncertainty, Meaningfulness, and Magnitude

Moderator: Greg Simon, MD, MPH

Panel:

  • Devon Check, PhD
  • Lynn DeBar, PhD, MPH
  • Juan Marcos Gonzalez, PhD
  • Laura Lee Johnson, PhD
  • Natalia Morone, MD, MS

▶️ Watch the Recording

Session 5: Toward Best Practices for Interpretation of Endpoints

Moderators: Adrian Hernandez, MD, MHS; Kevin Weinfurt, PhD

Panel:

  • Andrea Cook, PhD
  • Corita Grudzen, MD, MSHS
  • Liz Turner, PhD
  • Kari Stephens, PhD
  • Christy Zigler, PhD, MSEd

▶️ Watch the Recording

Summary and Concluding Remarks

Patrick Heagerty, PhD
Adrian Hernandez, MD, MHS
Greg Simon, MD, MPH
Kevin Weinfurt, PhD

September 8, 2026: NIH Collaboratory Training Resources Offer Practical Guidance for All Engaged in Pragmatic Clinical Trial Research

The NIH Collaboratory Living Textbook offers a variety of training resources intended for researchers, research team members, clinicians, healthcare system leaders and staff, and others involved in pragmatic clinical trial (PCT) research. These resources cover foundational information preparing learners to engage meaningfully with PCT research.

A Learning Modules section provides a series of self-paced videos featuring NIH Collaboratory experts covering PCT study funding, design, endpoint selection, and randomization strategies. Pathways to Learning provides comprehensive information on PCT study design while offering Continuing Education Units through the Duke University Health System’s Department of Clinical Education and Professional Development.

A wide range of videos, resources, and workshops provide learners with information, downloadable tools, guidance documents, templates, and relevant example materials from NIH Collaboratory Trials. Training resources are categorized by topic allowing research teams to easily find materials relevant to their interests.

All training resources can be accessed through the Living Textbook’s Training Resources page. New topics and materials are added frequently.

Innovations in Embedded Pragmatic Clinical Trials: Society for Clinical Trials (May 2026)

May 17, 2026: The NIH Pragmatic Trials Collaboratory hosted a preconference workshop, "Innovations in Embedded Pragmatic Clinical Trials,” at the 47th Annual Meeting of the Society for Clinical Trials in Phoenix. This training workshop introduces opportunities for embedded research along with strategies for conducting innovative ePCTs that provide real-world evidence necessary to inform improvements in healthcare.

Agenda and Slides

Welcome
Emily O'Brien, PhD

Session 1: Opportunities for Embedded Pragmatic Clinical Trials (ePCTs)
Wendy Weber, ND, PhD, MPH

Session 2: Engaging and Aligning With Partners
Emily O'Brien, PhD

Session 3: ePCT Design
Patrick Heagerty, PhD

Session 4: Innovative Methods in ePCTs
Angelo Volandes, MD, MPH

 

Session 5: Overview of NIH Collaboratory Trials
*This presentation contains case studies

Session 6: ePCTs in Context: Small Group Work and Panel Discussion With NIH Collaboratory Trial PIs
Moderators: Emily O'Brien, PhD; Nana Martinson, MPH
Panel: Sebastian Tong, MD, MPH; Michael Ho, MD, PhD

Closing Remarks
Emily O'Brien, PhD; Wendy Weber, ND, PhD, MPH

 

 

March 2, 2026: Registration Opens for Pragmatic Trials Workshop at SCT 47th Annual Meeting

Registration open, Innovations in Embedded Pragmatic Clinical Trials, a workshop at the Society for Clinical Trials 47th Annual MeetingThe NIH Pragmatic Trials Collaboratory will offer a preconference workshop at the Society for Clinical Trials 47th Annual Meeting in Phoenix. Registration for the workshop is now open.

The half-day workshop, “Innovations in Embedded Pragmatic Clinical Trials,” will introduce concepts in the design, conduct, and implementation of pragmatic clinical trials embedded in healthcare systems.

The workshop will provide an introduction to opportunities for embedded healthcare systems research, along with strategies for conducting patient-centered clinical trials that provide real-world evidence necessary to inform improvements in healthcare delivery. The workshop format is as follows:

  • A series of didactic presentations, each with ample time for attendee Q & A with presenters. Firsthand experiences with embedded pragmatic clinical trials and case studies from the NIH Collaboratory Trials will support and illustrate the topics presented.
  • A small group learning activity in which attendees work together to problem-solve real challenges encountered in embedded pragmatic clinical trials.
  • An interactive, facilitated panel discussion with experienced principal investigators from the NIH Collaboratory Trials.

Goals of the workshop:

  1. Describe the characteristics and utility of embedded pragmatic clinical trials
  2. Introduce attendees to the unique opportunities and challenges of designing, conducting, and implementing pragmatic trials within healthcare systems
  3. Explain how the latest information capabilities can be employed in embedded pragmatic trials to address important public health questions

The theme of this year’s SCT Annual Meeting is “Advancing Public Health: Clinical Trials in an Era of Cutting-Edge Information Capabilities.” The conference brings together the clinical trials community from academia, the pharmaceutical and device industries, government agencies, medical groups and centers, and clinical research entities.

WORKSHOP DETAILS AND REGISTRATION
Sunday, May 17, 1:00-5:00 pm
Arizona Grand Resort & Spa, Phoenix, Arizona

Dissemination and Implementation in Embedded Pragmatic Trials: Science-Powered Strategies to Sustain and Spread Effective Interventions: AcademyHealth (December 2025)

December 14, 2025: The NIH Pragmatic Trials Collaboratory hosted a workshop at AcademyHealth's 18th Annual Conference on the Science of Dissemination and Implementation in Health. The workshop introduced concepts in the design, conduct, and implementation of pragmatic clinical trials embedded in healthcare systems, with a focus on methods relevant to health services researchers.

Agenda and Slides

Morning Sessions

Welcome and Opening Remarks
Emily O'Brien, PhD

Session 1: Embedded Pragmatic Clinical Trials (ePCTs) and Hybrid Effectiveness-Implementation Trials: Similarities and Differences
Hayden Bosworth, PhD

Session 2: Design and Analysis Considerations
Qilu Yu, PhD

Session 3: Measuring Effectiveness and Implementation Outcomes
Angelo Volandes, MD, MPH

Session 4: ePCTs in Context: Small Group Work Followed by Panel Discussion With NIH Collaboratory Trial PIs
Moderator: Emily O'Brien, PhD
*This session includes case study presentations.

Afternoon Sessions

Session 5: Pilot and Feasibility Testing
Lanay Mudd, PhD

Session 6: Ethical and Regulatory Considerations and Posttrial Obligations
Stephanie Morain, PhD, MPH

Session 7: Engaging and Aligning With Health System and Community Partners
Hayden Bosworth, PhD

Session 8: Posttrial Sustainment or Deimplementation of Study Interventions
Vince Mor, PhD

Session 9: ePCTs in Context: Small Group Work Followed by Panel Discussion With NIH Collaboratory Trial PIs
Moderator: Stephanie Morain, PhD, MPH
*This session includes case study presentations.

Session 10: Writing a Compelling Grant Application
Beda Jean-Francois, PhD

Closing Remarks
Beda Jean-Francois, PhD

 

Digging Into Dilemmas of Pragmatic Clinical Trials: NIH Collaboratory Virtual Workshop (November 2025)

November 4-5, 2025: This 2-day workshop focused on the perspectives of providers, healthcare systems, regulators, and payers that can inform better approaches to research embedded in healthcare delivery. A series of panels discussed considerations for research in healthcare systems across a variety of communities; platform trials as an emerging method; implications of pragmatic trials with null findings for future pragmatic research; and the role of pragmatic trials in comparative effectiveness research of artificial intelligence algorithms.

Agenda, Slides, and Recordings

Day 1: November 4

Welcome and Introduction

Wendy Weber, ND, PhD, MPH*
Helene Langevin, MD*
Presented by: Lesley Curtis, PhD

Keynote: Landscape of Healthcare in America: Gaps and Opportunities (That Researchers Need to Hear)

David Zaas, MD, MBA

Session 1: Understanding Needs and Priorities of Health Systems Across Communities

Moderator: Cherise Harrington, PhD, MPH

Panel:

  • Aimee Eden, PhD, MPH*
  • Rachel Gold, PhD, MPH
  • Caleb Holtzer, MD, MPH
  • Ann Sheehy, MD, MS*
  • Sebastian Tong, MD, MPH

Session 2: Realizing the Potential of Platform Trials

Moderator: Adrian Hernandez, MD, MHS

Panel:

  • Marianne Kearney Chase
  • Martin Landray, MB ChB, PhD
  • Gregory Levin, PhD
  • Christopher Lindsell, PhD
  • Bijoy Menon, MBBS, MD, DM, MSc

Summary and Concluding Remarks

Lesley Curtis, PhD
Cherise Harrington, PhD, MPH
Adrian Hernandez, MD, MHS
Wendy Weber, ND, PhD, MPH*

Day 2: November 5

Welcome and Introduction

Wendy Weber, ND, PhD, MPH*
Helene Langevin, MD*
Presented by: Kevin Weinfurt, PhD

Session 3: What Do We Learn From Null Pragmatic Trials?

Presenter: Kevin Weinfurt, PhD

Moderator: Josephine Briggs, MD

Panel:

  • Corita Grudzen, MD, MSHS
  • Michael Ho, MD, PhD
  • Vincent Mor, PhD
  • Miguel Vazquez, MD

Session 4: What Is the Role of ePCTs in the Age of Artificial Intelligence?

Moderator: Emily O'Brien, PhD

Panel:

  • Adrian Hernandez, MD, MHS
  • Michael Ho, MD, PhD
  • Rohan Khera, MD, MS
  • Edward Melnick, MD, MHS
  • Jeremy Sugarman, MD, MPH, MA
  • Kenneth Wiley, PhD*


Summary and Concluding Remarks

Josephine Briggs, MD
Lesley Curtis, PhD
Emily O'Brien, PhD
Wendy Weber, ND, PhD, MPH*
Kevin Weinfurt, PhD

*Participated in workshop planning but unable to attend the live event due to the federal government shutdown.

September 29, 2025: Registration Opens for Pragmatic Trials Workshop at AcademyHealth–NIH Dissemination & Implementation Conference

Logo for the 18th Annual Conference on the Science of Dissemination and Implementation in HealthThe NIH Pragmatic Trials Collaboratory will offer a full-day workshop at the 18th Annual Conference on the Science of Dissemination and Implementation in Health in National Harbor, Maryland. The workshop, “Dissemination & Implementation in Embedded Pragmatic Trials: Science-Powered Strategies to Sustain and Spread Effective Interventions,” will introduce concepts in the design, conduct, and implementation of pragmatic clinical trials embedded in healthcare systems, with a particular focus on methods relevant to health services researchers.

The learning objectives of the workshop include:

  • To identify key areas of synergy between pragmatic trials and implementation research
  • To introduce attendees to the unique characteristics and challenges of designing, conducting, and implementing pragmatic clinical trials embedded within diverse health care systems, and to describe opportunities for integrating implementation research methods into pragmatic trials
  • To increase the capacity of health services researchers to address important clinical questions with embedded pragmatic clinical trials and share lessons from implementation science for supporting intervention adoption, sustainment, scale-up, and/or deimplementation

The theme of this year’s D&I conference is “Realizing the Benefits of Dissemination & Implementation Science.” The annual conference is cohosted by the NIH and AcademyHealth.

WORKSHOP DETAILS AND REGISTRATION
Sunday, December 14, 10:00 am-6:00 pm
Gaylord National, National Harbor, Maryland
Information and registration: https://academyhealth.org/page/2025-di-adjunct-events

Dissemination and Implementation in Embedded Pragmatic Trials: Getting the Timing Right in Real-World Research: AcademyHealth (December 2024)

A photo from the 2024 AcademyHealth D&I Workshop showing panelists at a dais answering questions from workshop participants.December 8, 2024: The NIH Pragmatic Trials Collaboratory hosted a workshop at AcademyHealth's 17th Annual Conference on the Science of Dissemination and Implementation in Health. The workshop introduced concepts in the design, conduct, and implementation of pragmatic clinical trials embedded in healthcare systems, with a focus on methods relevant to health services researchers.

Agenda and Slides

Morning Sessions

Welcome and Introduction
Emily O'Brien, PhD

Session 1: What Are Embedded Pragmatic Clinical Trials?
Beda Jean-Francois, PhD

Session 2: Trial Objectives and Design: An Overview of Hybrid Designs
Devon Check, PhD

Session 3: Engaging With Health System and Community Partners
Hayden Bosworth, PhD

Session 4: ePCTs in Context: Small Group Work and Panel Discussion With NIH Collaboratory Trial Investigators
Moderator: Angelo Volandes, MD, MPH
*This session includes case study presentations.

Afternoon Sessions

Session 5: Measuring Outcomes
Angelo Volandes, MD, MPH

Session 6: ePCT Design
Jonathan Moyer, PhD

Session 7: ePCT Analysis
Jonathan Moyer, PhD

Session 8: Pilot and Feasibility Testing
Beda Jean-Francois, PhD

Session 9: Ethical and Regulatory Oversight Considerations
Stephanie Morain, PhD, MPH

Session 10: Writing a Compelling Grant Application
Beda Jean-Francois, PhD

Session 11: ePCTs in Context: Small Group Work and Panel Discussion With NIH Collaboratory Trials Investigators
Moderator: Stephanie Morain, PhD, MPH
*This session includes case study presentations.

Closing Remarks
Emily O'Brien, PhD

 

December 3, 2024: Sharing Results With Research Participants Raises Special Considerations in Pragmatic Trials

Cover image of the journal Clinical TrialsIn a new report from the NIH Pragmatic Trials Collaboratory, a team of bioethicists explores the ethical obligation to share aggregate results from pragmatic clinical trials with research participants. They conclude with recommendations for how to meet this obligation.

The article was published online ahead of print in Clinical Trials.

There is growing appreciation of the importance of sharing aggregate results of clinical trials with research participants. However, this practice has not been examined in the context of pragmatic clinical trials, which have special features that may complicate the ethics and logistics of sharing aggregate results.

The report’s authors summarize the ethical arguments for sharing aggregate results and describe the features of pragmatic trials that may raise logistical and other barriers to disclosure. They also discuss the important role healthcare system partners play in sharing results from pragmatic trials.

The authors offer the following recommendations:

  • Sharing aggregate results with research participants should be the default, and decisions not to share should be justified
  • Planning for sharing aggregate results should begin early in the planning of the trial
  • The healthcare care systems in which the trial is embedded should be key partners in decisions about what and how to share
  • Proactive sharing of results from a pragmatic trial that was conducted under a waiver or alteration of consent, including an explanation for why consent was not obtained in the study, can promote trust in the investigators and their healthcare system partners

Read the full report.

The article was coauthored by members of the NIH Pragmatic Trials Collaboratory’s Ethics and Regulatory Core, including Stephanie Morain, Abigail Brickler, Joseph Ali, Caleigh Propes, and Kayla Mehl of Johns Hopkins University; Pearl O’Rourke, formerly of Partners HealthCare; Kayte Spector-Bagdady of the University of Michigan; Benjamin Wilfond of the Seattle Children’s Hospital; Vasiliki Rahimzadeh of the Baylor College of Medicine; and David Wendler of the NIH Clinical Center.

October 3, 2024: JAMA Commentary Highlights Gap Between Research Results and Implementation Decisions

Headshots of Richard Platt, Hayden Bosworth, and Greg SimonIn a JAMA Viewpoint published online this week, leaders from the NIH Pragmatic Trials Collaboratory discuss the discordance between the results of pragmatic clinical trials and the implementation of those results in healthcare settings, even in settings that championed the work.

Coauthors Richard Platt, Hayden Bosworth, and Gregory Simon posit that, to provide evidence that healthcare systems leaders will actually use, changes are necessary:

  • Trials need to be faster (2 to 3 years)
  • Trials should consider outcomes that healthcare system leaders care about (such as costs and subgroup analyses)
  • The evidence required for change should be at the level that healthcare system leaders use (such as not necessarily rejecting the null hypothesis at P < .05 but also considering results of Bayesian methods and interim analyses)

Read the full article.

“We believe it is possible to make pragmatic clinical trials of policies and procedures more useful to delivery systems by accommodating their priorities, introducing flexibility in the level of evidence trials require, shortening the duration of planning and implementation, addressing system leaders’ interest in multiple outcomes and subgroup analyses, encouraging modification of protocols during the implementation phase, and by providing timely interim analyses that can guide decisions about continuing or modifying an intervention,” the authors wrote.

This work was based on an NIH Pragmatic Trials Collaboratory workshop held in 2023, Getting the Right Evidence to Decision-Makers Faster. The workshop explored the critical cycle of evidence generation to decision by healthcare system leaders to implement the findings of pragmatic clinical trials conducted within healthcare systems.

Platt is a cochair of the NIH Collaboratory’s Distributed Research Network and the Harvard Pilgrim Health Care Institute Distinguished Professor of Population Medicine at the Harvard Pilgrim Health Care Institute and Harvard Medical School. Bosworth is a cochair of the Implementation Science Core and a professor in population health sciences at Duke University. Simon is the chair of the Health Care Systems Interactions Core and a senior investigator at the Kaiser Permanente Washington Health Research Institute.

View the full workshop materials.